---

---

positive   tags : N::A   

save search

---

Vision Sensing Acquisition Corp. Receives Positive Ruling from Nasdaq Hearings Panel
Published: 2024-04-19 (Crawled : 19:00) - globenewswire.com
VSAC | News | $11.13 0.0% 24K |

n/a

| Email alert Add to watchlist
nasdaq positive acquisition vision

---

Zscaler Positioned as a Leader in the 2024 Gartner® Magic Quadrant™ for Security Service Edge (SSE) for Third Straight Year
Published: 2024-04-18 (Crawled : 19:00) - globenewswire.com
IT | $440.38 -2.05% 0.0% 450K |

Commercial Services

| Email alert Add to watchlist
ZS | $169.23 -2.16% -2.21% 2.3M |

Technology Services

| Email alert Add to watchlist
gartner service year security for

---

LinkShadow is positioned as a Representative Vendor in the 2024 Gartner® Market Guide for Network Detection and Response (NDR)
Published: 2024-04-18 (Crawled : 14:00) - prnewswire.com
IT | $440.38 -2.05% 0.0% 450K |

Commercial Services

| -0.15% | O: -0.15% H: 0.0% C: 0.0%
gartner for network response market

---

NeuroSense Presents Positive Data Validating Phase 2b Topline Readout During Emerging Science Presentation at the American Academy of Neurology Annual Meeting
Published: 2024-04-18 (Crawled : 13:00) - neurosense.investorroom.com
NRSN | $1.435 -5.59% -5.92% 120K |

| -5.0% | O: -0.63% H: 1.89% C: -4.4%
neurology presentation readout positive topline meeting

---

Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson’s Disease
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
CERE | $42.15 0.02% 0.02% 810K |

Finance

| 0.78% | O: 0.78% H: 0.0% C: 0.0%
disease positive for topline parkinson’s trial therapeutics results living

---

Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
OCUL | $5.22 -10.92% -12.26% 9.1M |

Health Technology

| -5.78% | O: -5.78% H: 0.0% C: 0.0%
ocular positive for topline diabetic

---

Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
IMMP | $2.25 2.27% 2.22% 90K |

Health Technology

| -5.58% | O: -6.87% H: 0.0% C: 0.0%
tacti-004 lung positive cancer cell for trial

---

BranchOut Food Strengthens Financial Position with Successful Sale of Senior Secured Promissory Notes and Warrants
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
BOF | $1.13 -5.45% 3.7K |

| Email alert Add to watchlist
food financial

---

New Myriad Genetics Study Published in Prenatal Diagnosis Shows High Positive Predictive Value for 22q11.2 Microdeletion Syndrome Using Prequel® Prenatal Screen
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
MYGN F | $18.515 0.03% 0.03% 490K |

Health Technology

| -2.76% | O: -2.61% H: 0.0% C: 0.0%
prequel positive for study

---

Blue Biofuels Initiates Engineering and Design for Their CTS Commercial Plant Positioned to Produce Ethanol from Cellulosic Materials
Published: 2024-04-16 (Crawled : 12:00) - globenewswire.com
BIOF | $0.0877 34.16% 110K |

Information

| 6.29% | O: 0.36% H: 6.02% C: 5.9%
for commercial design blue

---

Intra-Cellular Therapies Announces Positive Phase 3 Topline Results from Study 501 Evaluating Lumateperone as Adjunctive Therapy in Patients with Major Depressive Disorder
Published: 2024-04-16 (Crawled : 11:00) - globenewswire.com
ITCI 1 d | $72.29 0.4% 0.4% 2.2M |

Health Technology

| 13.12% | O: 14.75% H: 12.75% C: 6.04%
positive topline therapy results study

---

Organovo Announces Positive Phase 2 Results for FXR314 in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Showing Both Reduction in Liver Fat Content and Strong Safety and Tolerability Compared to Placebo
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
ONVO | $1.11 -3.48% -3.6% 280K |

Health Technology

| 10.88% | O: 64.34% H: 4.82% C: -18.67%
fxr314 metabolic liver positive for results

---

Viracta Therapeutics Announces Positive Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial in Patients with Relapsed or Refractory Epstein-Barr Virus-Positive (EBV+) Peripheral T-Cell Lymphoma
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
VIRX | $0.88 -3.19% -3.3% 53K |

Manufacturing

| -20.34% | O: -12.71% H: 0.97% C: -24.27%
t-cell positive topline trial therapeutics results

---

Ultragenyx Announces Positive Interim Phase 1/2 Data in Patients with Angelman Syndrome After Treatment with GTX-102
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
RARE | News F | $42.37 -2.33% -2.38% 680K |

Health Technology

| -11.65% | O: -10.79% H: 0.0% C: -3.75%
gtx-102 positive treatment

---

TFF Pharmaceuticals Announces Additional Positive Data from the Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial Following Oral Presentation at the ISHLT 44th Annual Late Breaking Clinical Science Abstract Sessions
Published: 2024-04-15 (Crawled : 11:00) - globenewswire.com
TFFP | $3.35 6.86% 6.42% 3.7K |

Health Technology

| -18.39% | O: 0.25% H: 1.26% C: -11.56%
tacrolimus presentation positive sessions pharmaceuticals trial

---

Vallen Distribution Announces Key Executive Leadership Positions
Published: 2024-04-11 (Crawled : 14:00) - prnewswire.com
WCC F | $154.01 0.37% 0.0% 510K |

Distribution Services

| -8.68% | O: -0.62% H: 0.0% C: 0.0%
distribution key

---

Daré Bioscience Announces Publication in Contraception of Positive Efficacy and Safety Findings from a Pre-Pivotal Postcoital Test Study of Ovaprene®: an Investigational Hormone-Free Monthly Intravaginal Contraceptive
Published: 2024-04-11 (Crawled : 12:00) - globenewswire.com
DARE | $0.2838 -3.83% -3.98% 550K |

Health Technology

| -37.32% | O: 1.36% H: 0.68% C: -0.64%
ovaprene test positive bioscience publication contraceptive contraception study

---

Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
Published: 2024-04-11 (Crawled : 11:00) - globenewswire.com
IPSC | $3.06 2.86% 2.78% 110K |

Professional, Scientific, and T...

| -26.04% | O: 3.39% H: 11.53% C: 2.02%
disease million pipeline acquisition expansion therapeutics

---

Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
Published: 2024-04-11 (Crawled : 11:00) - prnewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M |

Finance

| -1.87% | O: -0.74% H: 0.09% C: -5.32%
LPCN | $5.33 -2.02% -2.06% 11K |

Health Technology

| -9.83% | O: 6.78% H: 13.49% C: 1.75%
obesity positive results

---

Moleculin Announces Presentation of Positive Data Demonstrating High Anti-Cancer Activity of Annamycin and Non-Cardiotoxic Properties
Published: 2024-04-10 (Crawled : 12:30) - prnewswire.com
MBRX | $4.65 2.8% 2.72% 11K |

Health Technology

| -13.58% | O: 8.8% H: 3.87% C: -8.61%
presentation positive

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---